Sort   by:  
 Page size 
UnknownTumor-associated soluble uPAR-directed endothelial cell motility and tumor angiogenesis.
Not available
S-EPMC3740303 | biostudies-literature
UnknownHepatic Overexpression of Soluble Urokinase Receptor (uPAR) Suppresses Diet-Induced Atherosclerosis in Low-Density Lipoprotein Receptor-Deficient (LDLR-/-) Mice.
Not available
S-EPMC4551736 | biostudies-literature
UnknownInterferon alpha-induced uPAR expression on monocytes as a potential source of increased soluble uPAR in patients with SLE at high risk of developing organ damage.
Not available
S-EPMC12540527 | biostudies-literature
UnknownTumour microenvironments induce expression of urokinase plasminogen activator receptor (uPAR) and concomitant activation of gelatinolytic enzymes.
Not available
S-EPMC4144900 | biostudies-literature
UnknownuPAR regulates bronchial epithelial repair in vitro and is elevated in asthmatic epithelium.
Not available
S-EPMC3358731 | biostudies-literature
UnknownUrokinase-type plasminogen activator receptor (uPAR) assessed by liquid biopsies and PET/CT for prognostication in head and neck cancer patients.
Not available
S-EPMC9645757 | biostudies-literature
UnknownRational Design and In Silico Evaluation of a Multiepitope Vaccine Targeting the uPAR for Cancer Immunotherapy.
Not available
S-EPMC12531433 | biostudies-literature
UnknownuPAR isoform 2 forms a dimer and induces severe kidney disease in mice.
Not available
S-EPMC6486353 | biostudies-literature
ProteomicsPlasma gradient of soluble urokinase-type plasminogen activator receptor is linked to pathogenic plasma proteome and immune transcriptome and is a prognostic biomarker for severe COVID-19
The disease caused by the novel coronavirus of 2019 (COVID-19) has resulted in significant morbidity and mortality world-wide. A systemic hyper-inflammation characterizes the severe COVID-19 disease often associated with acute respiratory distress syndrome (ARDS). Bloodbiomarkers with prognostic rel...
ORGANISM(S): Homo sapiens (Human) 
2023-07-17 | PXD026510 | Pride
Ards Soluble upar Plaur Myeloid cells Covid-19 Prognosis 
OtherCancer agnostic potential of CAR T cells targeting the urokinase plasminogen activator receptor
Chimeric Antigen Receptor (CAR) T cells have demonstrated transformative efficacy in hematologic malignancies and have shown promise in non-cancer contexts such as autoimmune diseases. We previously identified the urokinase plasminogen activator receptor (uPAR) as a cell-surface protein expressed on...
ORGANISM(S): Homo sapiens 
2026-03-31 | GSE293800 | GEO
Sort   by:  
 Page size